Cargando…

5613260 A PHASE -- IIA-IIB, OPEN LABEL, SINGLE CENTER TRIAL TO STUDY SAFETY, TOLERABILITY AND EFFICACY OF MEMANTINE AS SUPPORTIVE LONG-TERM TREATMENT OF SICKLE CELL PATIENTS: TRIAL DESIGN AND ENROLLMENT

Detalles Bibliográficos
Autores principales: Levin, C.L., Koren, A.K., Peretz, S.S.P., Livshits, L.L., Makhro, A.M., Bogdanova, A.B., Gassmann, M.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112626/
http://dx.doi.org/10.1097/01.HS9.0000928448.56489.99